ScholarWorks@Gachon: Choi, Kyung Hee

Detailed Information

Choi, Kyung Hee (최경희)

Pharmacy (Dept.of Pharmacy)

Research Area: 약물안전사용, 약울유전체학, 집단약동학, Drug Safety, Pharmacogenomics, Population Pharmacokinetics

Tel 032-820-4933
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Adherence:3||biomarkers:3||hepatotoxicity:3||drug labeling:3||Aged:3||male:2||education:2||Attitude:2||Offlabel use:2||Pharmacogenomics:2||persistence:2||Pediatrics:2||DOAC therapy:1||Dapagliflozin:1||Data monitoring committee (DMC):1||Dementia:1||Drug Interactions:1||Drug labeling:1||EMC:1||Emergency preparedness:1||Examination:1||FDA:1||Genetic polymorphisms:1||H2 blocker:1||HMGCoA reductase inhibitors:1||Health Personnel:1||Health education:1||Health knowledge:1||Hospice care:1||Hypertension:1||Hypoglycemia:1||Infant:1||Innovative CBT item types:1||Intensive care unit:1||Job satisfaction:1||Kidney transplantation:1||Licensure:1||MERS:1||Meta analysis:1||Neonatal:1||Nephrotic syndrome:1||Newborn:1||NonSteroidal:1||Nonalcoholic fatty liver disease:1||Omega n3 polyunsaturated fatty acids:1||Overthecounter drugs:1||PF4:1||PMDA:1||Pain control:1||Patient safety:1||Pediatric Intensive Care Units:1||Persistence:1||Pharmacist specialty certificate:1||Polypharmacy:1||Potentially inappropriate medication:1||Rheumatoid arthritis:1||SDF1:1||Selfevaluation:1||Selfmedication:1||Sitagliptin:1||Sponsor:1||Steroiddependent nephrotic syndrome:1||Sulfonylurea:1||T521C polymorphism:1||Terminal care:1||Therapeutic Class:1||Thrombocytopenia:1||Treatment persistence:1||Type 2 DM:1||Type 2 diabetes mellitus:1||Uncomplicated Hypertension:1||Very elderly:1||Warfarin:1||acetaminophen:1||adherence:1||adverse drug reaction:1||age:1||anemia:1||anemia of chronic disease:1||angiotensinreceptor blocker:1||asthma:1||atenolol:1||betaxolol:1||bleeding:1||cardiovascular events:1||dapagliflozin:1||dental visit:1||depression:1||dipeptidylpeptidase IV inhibitors:1||direct oral anticoagulant:1||dose:1||empagliflozin:1||fibrinogen:1||genetic testing:1||genotype:1||hypertension:1||immune checkpoint inhibitor:1||inflammation:1||intent:1||kidney transplantation:1||knowledge:1||losartan:1||machine learning:1||malignancies:1||medication:1||medication use:1||methotrexate:1||newgeneration beta blocker:1||nilotinib:1||oral health:1||pediatric:1||personalized medicine:1||pharmacogenomic information:1||pharmacogenomics:1||pharmacovigilance:1||pharmacy practice experience:1||polymorphism:1||practice:1||precision medicine:1||pregnancy:1||realworld data:1||retrospective study:1||safe use:1||safety:1||sodiumglucose transporter 2 inhibitors:1||student:1||tacrolimus:1||thrombin:1||trough concentration:1||women:1||Adverse drug reactions:1||And practice:1||AntiInflammatory Agents:1||Antiinflammation effect:1||Anticholinergic agents:1||Anticholinergic burden scale:1||Breastfeeding:1||CYP3A4*22:1||Cancer:1||Computerbased test:1||Cyclosporine:1||

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE